A B S T R A C T Concentrations of IgD and IgE were measured in sera from 165 patients with well-defined immunodeficiency in an effort to find information possibly relevant to the roles of antibodies of these classes in host defense. Values for both immunoglobulins were generally quite low in patients who had marked deficiencies of all three major immunoglobulins, although occasional normal or high normal values for IgD were seen in hypogammaglobulinemic patients. Group mean IgD concentrations were also depressed in patients with Wiskott-Aldrich syndrome and in those with selective IgA deficiency; IgE concentrations were depressed in patients with X-linked immunodeficiency with hyperIgM and in those with ataxia telangiectasia. IgD and IgE were both significantly elevated in patients with extreme hyperimmunoglobulinemia E and undue susceptibility to infection and in a patient with the Nezelof syndrome; none of these patients had histories suggestive of atopy. In addition, the mean IgE concentration was significantly elevated in patients with selective IgA deficiency, many of whom were atopic, and in those with the Wiskott-Aldrich syndrome. The highest IgD concentration (163 mg/100 ml) was found in serum from a boy with variable immunodeficiency who had a lifelong history of severe recurrent pharyngeal infections, primarily streptococcal in etiology. Recurrent staphylococcal infection was a feature common to many but not all patients with elevated IgD and IgE. Depressed cell-mediated immunity was present in many patients with elevated serum IgE concentrations. These data may prove useful in the future delineation of biologic roles for antibodies in these two immunoglobulin classes.
INTRODUCTION
Numerous reports have documented a wide variety of abnormalities in concentrations of the three major im-munoglobulins, IgG, IgA, and IgM, in patients with immunodeficiency (1) . Less is known, however, about concentrations of IgE in such patients (2) (3) (4) (5) (6) (7) (8) (9) (10) , and information on IgD concentrations in immunodeficiency can be found primarily only in limited studies (2, 11, 12) or case reports (13) . Considerable knowledge has been derived from the study of patients with immunodeficiency diseases about the host defense roles played by various components of the immune system. Since it is unknown whether antibodies of the IgD and IgE classes function in host defense, knowledge of deficiencies or elevations of these proteins in particular groups of infection prone immunodeficient patients may provide some clues as to their biologic function. In the case of IgD antibodies no clearly identifiable biologic activity has yet been found, and indeed, there are only a few reports of antibody activity in molecules having the antigenic properties of IgD (14) (15) (16) (17) . It is known, however, that IgD molecules do not cross the placenta, are not present in body secretions or urine (12) , and do not fix complement or sensitize guinea pig skin for passive cutaneous anaphylaxis (18, 19) . IgE antibodies do not cross the placenta or fix complement but are known to be present in external secretions and to bind to basophils and mast cells (20) . IgE antibodies so bound effect the release of histamine and the slow reacting substance of anaphylaxis upon combination with antigen, causing both anaphylactic and atopic types of immediate hypersensitivity.
In the present study we (24) . When antiruminant antibodies present in many of the study patients' sera (especially those with either A Def or W-A) were found to give falsely high results in this modification, the method required further revision so as to eliminate ruminant antisera. Assays involving sera containing antiruminant antibodies or sera from patients entering the study during the latter part included the following reagents: (a) rabbit anti-Fc IgE, raised against PS Fc fragment isolated by agarose block electrophoresis of papain-digested, purified PS, (b) pony antirabbit IgG, prepared by immunizing a pony with DEAE cellulose purified rabbit IgG and repeatedly absorbing the antiserum with normal human serum, and (c) purified Bedore IgE myeloma protein, obtained from Dr. Roy Wood of the Immunoglobulin Reference Center, Springfield, Va. and radiolabeled as above. Serum from one of the study patients (B. S.) with extreme hyperimmunoglobulinemia E and undue susceptibility to infection (4) was calibrated against a research standard (68/341) for IgE, obtained from the WHO Reference Center for Immunoglobulins, and found to have 22,300 U/ml. B. S. serum was used as the secondary reference standard in all IgE assays. Because of lack of agreement among various investigators as to the absolute concentration of IgE in the WHO reference standard (25) , all IgE data are expressed as units per milliliter, the stated value of 9,346 U/ml in the WHO standard being used as a reference.
Statistical nethods. All data were transformed logarithmically for statistical analysis, since concentrations of immunoglobulins G, A, and M have been shown to have a logarithmic gaussian distribution (26) . For the logarithmic transformation, undetectable IgD values were called 0.1 mg/ 100 ml and IgE values 1 U/ml. Since both the IgD and IgE concentrations in the control groups were found to have multimodal distributions, however, the differences between group IgD and IgE concentrations were tested by the Mann-Whitney U test for differences of medians (27). Student's t test was also used to test differences between group mean log IgD and IgE concentrations. 95%o confidence intervals were obtained by taking the antilogs of the mean logarithms ±2 pooled SD of the logs of the data, as previously described (21) . Fig. 1 ). Group medians were also quite low in Trans Ag, SCID, X Ag, Hyp M, and W-A, although these differences did not prove to be statistically significant in the Mann-Whitney U test. The group median IgD concentration was significantly elevated in patients with Hyp E; medians for A-T, Nez, and CGD patients were also elevated but differences were not significant in the Mann-Whitney U test. IgD was not detectable in the sera of a majority of individuals in groups with very low mean IgD values, but three patients with X Ag, three with Non-X Ag, one with Hyp M, two with W-A (Fig. 1 the individual values, with one exception, were all lower than the group mean for normal children and adults (Fig. 2) . The exception was a 9-mo-old infant with SCID who had been given a large quantity of gamma globulin a few days before the serum sample was obtained; however, since the amount of IgE in commercial gamma globulin is negligible and the half-life of IgE in serum is 2-3 days, it is likely that the IgE was produced by the infant.
It is apparent that the presence of atopy had a major influence on the serum IgE concentrations in A Def's ( Fig. 3) since, when those patients were grouped according to the presence or absence of atopy, the IgE concentration of the nonatopic A Def's did not differ significantly from normal (Table IV) . On the other hand, the atopic A Def median of 270 U/ml was highly significantly different. Since the W-A patients by definition all had a pruritic dermatitis resembling allergic eczema, it is likely that atopy is also related to their elevated serum IgE concentrations (Fig. 2) .
In contrast to the above groups, the patients with Hyp E, Nez, and Var ID, who in many cases had extremely elevated concentrations of IgE, did not have histories suggestive of atopy. One patient in the CGD group had an IgE value above the 95% confidence interval of the normal group (Fig. 2) . The latter patient was not atopic but had multiple staphylococcal liver abscesses at the time the blood sample was obtained.
Relationship between IgD and IgE concentrations. Since patients with Hyp E had the highest mean IgD concentration of any of the groups, this raised the question of a possible positive correlation between the concentrations of these two immunoglobulins. This association was also seen in CGD patients and in Nez patient DR and Var ID patient DC. Nevertheless, the correlation was not borne out in the other groups, since patients with A-T had elevated IgD and decreased IgE, and patients with W-A and A Def had decreased IgD and increased IgE. DISCUSSION Although IgD was discovered over 9 yr ago (28) and much information has been obtained pertaining to its physicochemical structure (28) , metabolism (29) , biologic activity (18, 19) , and distribution in body fluids and tissues (12) , there are few clues as to its role in the immune response and in host defense. Of considerable interest is the recent observation that a high proportion of human peripheral blood lymphocytes bear surface (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) , very little is known about IgD levels in disease states or in immunodeficient humans. The finding in the present study of detectable IgD in only 39 of 79 (49%) A Def's as compared with its detection in 75 of 105 (71%) normal children, and 46 of 57 (81%) normal adults is similar to the findings of Johansson, Hogman, and Killander (11) . This suggests that IgD deficiency may be common among A Def patients. While IgD was found to be undetectable in 85% of 78 patients with idiopathic hypogammaglobulinemia studied by Rowe, Crabbe, and Turner (12), concentrations up to 33 mg/100 ml were found in the remainder. This is in keeping with the finding in the present study of normal to high normal concentrations of IgD in a few patients with X Ag and Non-X Ag.
Patients in this study who had the highest concentrations of IgD did not bear any obvious clinical resemblance to each other, except that recurrent staphylococcal infections predominated among the CGD and Hyp E patients, and Var ID patients J. C. and D. C. In contrast, Var ID patient J. T., who had the highest serum IgD concentration (163 mg/100 ml) had as his sole clinical problem recurrent and severe pharyngeal infections; the latter were proven to be of streptococcal etiology on a number of occasions. Despite this, the patient had very low titers of anti-DNase B, anti-NADase, and antigroup A carbohydrate streptococcal antibodies. The restriction of this boy's infections to the naso- The possibility that chronic infection alone could cause elevated concentrations of IgD has been raised previously (12) . The finding of elevated IgD in tuberculosis (38) , leprosy (12) , and in the CGD and Hyp E patients in the present study would suggest this. Contrary to this is the fact that many other of the study patients who were chronically infected had low or undetectable quantities of IgD, including some of the CGD patients. Moreover, Rowe, McGregor, Smith, Hall, and Williams (37) found IgD concentrations to be normal in malaria and in members of a West African (Gambian) community where chronic parasitic infestation and infections are likely to be common. IgD was found to be normal in patients with various types of autoimmune diseases (12) but elevated approximately threefold over normal in pregnant women (39) .
The observed deficiency of serum IgE in X Ag, Non-X Ag, SCID, and A-T is in keeping with the findings of others (5) (6) (7) (8) (9) (10) (3) . It would appear that a high incidence of atopy in these patients is the primary reason for this. Since most of the A Def individuals in the present and previous study were drawn from patients referred to an allergy clinic, however, it is impossible to say whether the observed increased incidence of atopy reflects an increase in atopy among A Def patients in general.
The elevated IgE concentrations found in the W-A patients in this report are in keeping with those found by others (2, 6) and are possibly related to these patients' dermatitis. An alternative hypothesis, however, is that the impaired cell-mediated immunity in this condition, in the Hyp E patients, in Nez patient D. R., and in Var ID patient A. P., is causally related to the augmented IgE production. A precedent for such a relation is seen in the experimental work of Tada and coworkers (43) (44) (45) who have produced enhanced IgE antihapten antibody formation in rats by treating them with small doses of antithymocyte serum, 400 R whole body irradiation, adult thymectomy and splenectomy, or by giving various immunosuppressive drugs before or shortly after immunization. The common facilitating factor in those treatments appeared to be depression of T (thymusderived)-cell immunity, since other studies by these workers showed that administration of syngeneic carrier-specific T lymphocytes to such animals could abrogate the enhanced IgE antibody production (46) . In support of the possibility that overproduction of IgE may be related to depressed T-cell immunity in man is that, except for the A Def patients in the present study, all immunodeficiency patients with excessive IgE production in this and other reports (4, 7, 42) have also had impaired cell-mediated immunity. It is possible that even A Def patients may have a T-cell subpopulation deficit, since they recently have been shown to have decreased percentages of T-cell rosettes (34) and impaired interferon production by phytohemagglutinin-stimulated lymphocytes (47) .
A third factor possibly related to increased IgE production in certain of these immunodeficiency patients is chronic infection, particularly with staphylococcal organisms. Features of the nine additional patients with extreme hyperimmunoglobulinemia E and undue susceptibility to infection (Table II) Although no clear patterns of infection susceptibility associated with deficiencies or excesses of IgD and IgE production emerge from the observations in this report, it is hoped that the trends noted will prove helpful in the future definition of biologic roles for these proteins.
